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Abstract
To investigate the etiology of malignant hyperthermia and central core disease,
mouse models have recently been generated and characterized (Chelu et al., 2006).
These RyRY522S/+ knock-in mutant mice provide an excellent tool to investigate calcium
dysregulation, its pathological consequences, and potential therapeutic approaches.
Skeletal muscle harboring this mutation exhibits calcium leak from internal stores and an
increased sensitivity to activation by caffeine, voltage, and temperature (Durham et al.,
2008). Although alterations in RyR1 channel function and resultant changes in cellular
function have been characterized in skeletal muscle, the effects of MH mutations in RyR1
on central nervous system function have not been investigated. Since RyR1 is highly
expressed in cerebellar Purkinje neurons, our goal is to investigate whether the RyRY522S/+
mutation causes altered calcium handling and whether potential calcium dysregulation
alters cellular function.
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Chapter One: Introduction
Calcium plays an important role in cellular signaling and function, yet calcium
can also trigger pathology and cell death. Cytosolic calcium originates from two main
sources: influx of extracellular Ca2+ through voltage- or ligand-gated ion channels in the
plasma membrane and release from intracellular Ca2+ stores through ryanodine receptor
(RyR) or inositol 1,4,5-trisphosphate receptor (IP3R) channels in the sarcoplasmic (SR)
or endoplasmic (ER) reticular membrane. Cytosolic calcium can act as a second
messenger through downstream activation of a myriad of effectors; among these targets
are calpains and other apoptotic machinery, so free calcium must be tightly regulated.
Extensive measures are employed by a cell to maintain calcium homeostasis, but even
slight alterations in these tightly controlled processes can disrupt the fine balance of
control. Furthermore, calcium dysregulation is the underlying mechanism for a number
of different human disorders. Malignant hyperthermia, for example, is a skeletal muscle
disease that is associated with disrupted function of the RyR1 in the presence of certain
triggering agents, including volatile anesthetics, depolarizing muscle relaxants, and
environmental or exertional heat stress (Durham et al., 2008). The RyR1 is the “skeletal
muscle” isoform of the RyR and is highly expressed in this tissue, but also exhibits
limited expressions by certain cell types within the brain (Giannini et al., 1995).
Cerebellar Purkinje neurons (PN) are one of these cell types, and calcium dysregulation
within PNs could have profound effects on not just cellular function, but organismal
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function as well. Purkinje neurons are the integrator and sole output of the cerebellar
cortex (Ito et al., 1984), therefore serving as an essential step in the cerebellar signaling
pathway. Disruptions in calcium signaling in these cells can result in loss of motor
coordination and ataxia, but the specific effects of altered RyR1-mediated calcium release
on PN and/or cerebellar function have not been determined. Furthermore, the normal
functional role of the RyR1 in PNs is not fully understood. Recently, a model of
malignant hyperthermia (MH) has been created in a knock-in mouse by substitution of a
tyrosine for a serine at residue 522 (Y522S) in RyR1 (Chelu et al., 2006). The function
of the mutant form of this channel has been characterized in skeletal muscle, and the
heterozygous form of this mutation has been shown to exhibit a decreased threshold for
activation by agonists and an increased intracellular calcium concentration at
physiological temperatures, likely due to enhanced basal channel activity of the RyR1
(Chelu et al., 2006; Durham et al., 2008). This “hyperactive” RyR1 could serve as a
unique tool to assess the function of RyR1 in PNs, the effects of altered RyR1 release in
PNs, and the neurological consequences of MH. To understand altered function of the
RyR1 in PNs, however, it is first important to understand what is known about the normal
functioning of the channel.
Ryanodine Receptor 1
The RyR1 is a calcium release channel on the SR membrane that acts as a source of
calcium for excitation-contraction coupling in skeletal muscle (Otsu et al., 1990). In
PNs, however, the function of this channel in the ER membrane is less clear. Three
isoforms of the RyR are expressed in mammals and each of these three isoforms
functions as a calcium release channel. There are two known modes of activation
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associated with the RyR. The first is calcium-induced calcium release (CICR), whereby
the calcium fluxed through voltage-gated calcium channels serves as the agonist for the
RyR (Endo, 1977). The second is mechanical coupling, whereby membrane
depolarization induces a conformational change in L-type voltage-gated calcium channels
(DHPR) that triggers release of Ca2+ through the RyR1 by a direct physical interaction
(Tanabe et al., 1990). The RyR1 is unique in that it is the only isoform of the three
known to be activated by mechanical coupling (Tanabe et al., 1990).
The RyR1 was originally isolated in skeletal muscle, where it is highly expressed and
localized to the junctional SR, defined by the close proximity of T-tubule invaginations to
terminal cisternae of the SR. Freeze-fracture analysis of junctions in skeletal muscle
(Protasi et al., 1997) revealed tightly compacted, two-dimensional arrays of RyR1s on the
SR membrane and clustering of four DHPRs, in opposition to every other RyR, in the
sarcolemmal membrane. Each DHPR interacts with a different subunit of the RyR1,
which is a homotetramer with a molecular mass of over 2 MDa. Each RyR1 subunit is
approximately 565 KDa (Inui et al., 1987; Lai et al., 1988), and this large size makes the
RyR the largest known ion channel. The majority of the RyR1 mass, about 80%, resides
within the cytoplasm, while only 20% of the protein is located in the luminal and
transmembrane space (Hamilton, 2005). The N-terminal domain comprises the large
cytoplasmic portion of the RyR, while the C-terminal domain forms the pore and
transmembrane region of the channel (Fill et al., 2002).
Regulation of this enormous channel is quite complex (Fig 1); there are three main
regulatory domains controlled by calcium, ATP and magnesium binding, two of which
are cytoplasmic. The first is a high affinity, specific cytoplasmic calcium activation site
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known as the A-site, which also allows competitive binding of magnesium and
monovalent cations (reviewed by Laver, 2005). The second regulatory domain is a nonspecific, low affinity, inhibitory cytoplasmic region known as an I-site. Magnesium
potently inhibits the channel when bound to either or both sites, while calcium can act as
both an activator and an inhibitor depending upon cytoplasmic calcium concentration
(reviewed by Laver, 2005). Isolated RyR1s are activated at approximately 1 µM [Ca2+]i
and inhibited at approximately 1 mM [Ca2+]i (Meissner 1994). There is also evidence of
a luminal regulatory domain sensitive to calcium levels, but it is unknown exactly what
region of the RyR1 serves as this luminal site or whether luminal regulation is controlled
by an associated protein.

Figure 1: Schematic of RyR1 regulation
Adapted from Lanner et al., 2005
4

There are two theories regarding luminal calcium regulation of the channel. The first
theory, direct luminal activation, posits that calcium binding to a regulatory domain
within the lumen allosterically modifies A-site affinity to Mg2+ (reviewed by Laver,
2007). Once Mg2+ inhibition of the A-site has been relieved, calcium and ATP are free to
bind and activate the channel. The second theory, calcium feed-through, involves the
release of luminal calcium through the channel when the concentration of calcium within
the ER store is high and relieving Mg2+ inhibition by competitively binding at the A-site
(reviewed by Laver, 2007). These theories are not mutually exclusive, and it is more than
likely that both play a role in RyR activation.
One potential candidate for a luminal regulatory domain is calsequestrin.
Calsequestrin interacts with the RyR1 in conjunction with two other proteins: junctin and
triadin (Zhang et al., 1997). Calsequestrin acts as both a calcium buffer and a calcium
sensor, and its structural arrangement is modified by luminal calcium concentration
(Beard et al., 2009). In the presence of low levels of luminal calcium, calsequestrin is not
bound to calcium, dissociates from the channel complex and de-polymerizes. At
physiological levels of luminal calcium, approximately 1 mM, calsequestrin binds
calcium, polymerizes and attaches to junctin and triadin. Through its binding to junctin it
inhibits RyR1 activity and thus maintains appropriate calcium concentrations within the
ER. At higher levels of calcium, calsequestrin polymers become super-compacted and
dissociate from junctin and triadin, and the inhibition of RyR1 is removed (Beard et al.,
2004).
The RyR is part of a macromolecular complex of proteins many of which attach to
the large cytoplasmic scaffolding domain of the RyR. RyR1 is known to associate with
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PDE4D3 (bound to the receptor by mAKAP), PKA, FKBP12 (calstabin), CaM, and PP1
(through binding to spinophilin) (Bellinger et al, 2008). When each subunit of the RyR
binds a calstabin molecule, the closed state of the channel is stabilized (Lanner et al.,
2005). Calstabins also play a role in coordinating the gating of the four subunits of the
RyR and in coupling the opening of neighboring channels (Brillantes et al., 1994; Avila
et al., 2003). Protein kinase A (PKA) phosphorylation of the channel on Ser 2844 can
lower the affinity of calstabin binding and results in activation. Hyperphosphorylation at
this residue causes depletion of calstabin binding and can result in calcium “leak” by
destabilizing the closed state of the channel (Reiken et al, 2003).
Calmodulin, another protein capable of binding to the RyR, regulates the channel
differently dependent upon cytoplasmic calcium concentration. Calmodulin has four
calcium binding sites, two on the N-terminus and two on the C-terminus (reviewed in
Jiang et al., 2010). The N-terminal sites have a ten-fold lower calcium affinity than the
C-terminal sites. When calcium binds the C-terminal calcium binding domains,
calmodulin switches from an activator into an inhibitor (Jiang et al., 2010).
The RyR1 itself can act as a regulator of neighboring RyR1s. Calcium released
through an individual channel will not affect that same channel since the A-site is
inaccessible to calcium feedthrough while in an open configuration (Laver et al., 2004).
This calcium does have an effect on neighboring channels, however, and removes Mg2+
inhibition by competitively binding at the A-sites.
Even with this extensive regulation of the RyR, however, a single point mutation
within the channel can result in severe pathology. Missense mutations in the RyR1 can
result in malignant hyperthermia (MH), central core disease, and multi-mini core disorder
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(Betzenhauser and Marks, 2010). MH is a disorder characterized by an increased
sensitivity of the RyR1 to activation, and mouse models of MH have recently been
created and characterized in skeletal muscle (Chelu et al., 2006; Durham et al., 2008).
Malignant Hyperthermia
Malignant hyperthermia is a pharmacogenetic disorder, meaning that it is
hereditary but the major symptoms are not overtly expressed unless the individual is
exposed to volatile anesthetics, depolarizing muscle relaxants, or heat stress. The
incidence of diagnosed anesthetic-induced MH is approximately 1 in 14,000 for the
pediatric population and 1 in 50,000 for the adult population (MacLennan, 1992). MH
susceptibility may actually be closer to 1 in 2,000-3,000 since prevalence is difficult to
determine; MH is only apparent after exposure to triggering agents (Monnier et al.,
2002). However, diagnosis is possible using the in vitro contracture test prior to
administering anesthesia. Biopsied skeletal muscle fibers are submerged in baths
containing either halothane or caffeine, and if the muscle cells are hypersensitive to both
of these agents, the individual will be diagnosed as malignant hyperthermia susceptible
(MHS). When an MHS individual undergoes anesthesia, the RyR1 releases excessive
amounts of calcium from the SR, resulting in sustained whole-body muscle contracture,
elevated body temperature, and rhabdomyolysis; without treatment this is a fatal response
in 80% of cases (reviewed by Lanner et al., 2010). Currently, dantrolene, an RyR
antagonist, is the only known treatment for MH (reviewed by Lanner et al., 2010).
Although mutations in the DHPR can result in MH (Carpenter et al., 2009), missense
mutations in the RyR1 are the main cause of the disorder. There are three different
regions within the RyR1 which account for the loci of the vast majority of MH mutations.
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These regions include the N-terminus, a myo/cytoplasmic domain, and a small portion of
the C-terminus which resides in the lumen of the ER/SR (McCarthy et al., 2000). The
RyR1Y522S/+ mutation is located within the N-terminal domain
There are two different mechanisms theorized to underlie MH and/or CCD; the
“leaky” RyR1 hypothesis, and the excitation-contraction uncoupling hypothesis (Dirksen
and Avila, 2002). The Y523S mutation in the RyR1, the human equivalent of the Y522S
mutation in mice, has been attributed to the “leaky” hypothesis (Dirksen and Avila,
2002). In most MH mutations, this leak can for the most part be compensated for by the
calcium reuptake, extrusion and buffering machinery of the cell (Bellinger et al., 2008;
Dirksen and Avila, 2002). Thus, SR calcium stores remain relatively full and basal
cytoplasmic calcium levels close to normal. However, uncompensated calcium leak can
result in CCD (Bellinger et al., 2008). Thus, calcium store depletion ensues, leaving little
calcium for release during stimulation and subsequently only weak muscle contraction.
A number of proposed mechanisms for the cause of leaky RyR1 exist, and leaky
RyRs have actually been associated with a number of different disorders. The Y522SRyR1 mutation, associated with MH in mice, causes a calcium leak through the RyR1
that results in an elevated intracellular calcium concentration triggering the production of
reactive nitrogen species (RNS) by nitric oxide synthases (NOS) (Durham et al., 2008).
An increased basal level of RNS results in S-nitrosylation of the RyR1, which actually
serves to amplify the inherent leak present in mutant channels (Durham et al, 2008).
Calcium leak through the RyR1 (due to either an MH or CCD mutation) alters the normal
functioning of skeletal muscle cells in multiple ways including a reduced threshold for
luminal Ca2+ activation (Jiang et al., 2008), an altered retrograde signal from RyR1 to the
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DHPR which results in a leftward shift in DHPR inactivation and window calcium
release (Andronache et al., 2009), enhanced excitation-coupled Ca2+ entry
(Cherednichenko et al., 2008), and altered sensitivity to temperature, activators, and
redox modifications (Durham et al., 2008). The phenotype of this disorder has been well
characterized in skeletal muscle, but RyR1 is also expressed in a number of different
tissues including cerebellar PNs (Fig 2; Giannini et al., 1995). PNs are an extensively
studied cell type, and calcium signaling within these cells is essential for normal
functioning of the entire cerebellum, yet the specific role of RyR1 is not fully understood.
An MH mutation in the RyR1 could serve as a unique tool to study altered RyR1 channel
function in PNs.

Figure 2: RyR1 is expressed in the cerebellum
Adapted from Giannini et al., 1995

Purkinje neurons
Purkinje neurons are the integrator and sole-output of the cerebellar cortex (Ito,
1984). Four types of cells provide input to PNs (Schilling et al., 2008). Two inputs are
inhibitory, GABA-ergic synapses: stellate and basket cells. The other two of these inputs
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are excitatory, glutamatergic synapses: parallel fibers, originating from granule neurons,
and climbing fibers, originating from the inferior olive.
The first input, parallel fibers, synapse onto the dendrites of PNs and elicit two
different types of responses. A single stimulus from the parallel fiber produces only
small and local Ca2+ signals in PNs (Eilers et al., 1995). Repetitive parallel fiber stimuli
create a biphasic Ca2+ response “the simple spike” (Fig 3; reviewed by Hartmann and
Konnerth, 2005). The first phase is the result of Na+ currents through the AMPAR that
depolarize the membrane and trigger Ca2+ entry through voltage gated P-type calcium
channels. The second phase of the response is mediated by mGluR1 activation which in
turn triggers the release of the G-proteins Gαq and Gα11. Phospholipase Cβ, which is
activated by the G-proteins, cleaves IP3 from PIP2 and thus triggers calcium release
through the IP3R (Hartmann et al., 2005). Even this second type of response is local and
remains in small dendritic regions and sometimes even single spines (Hartmann et al.,
2005). Recent evidence suggests that RyRs may play a role in amplifying the second
phase of this response through CICR. If a dendritic spine receives a strong enough
repetitive stimulus, calcium fluxed into the cell through VGCCs and released through the
IP3R can diffuse out of the spine and into the dendritic shaft where RyRs are located.
Resultant CICR through the RyRs is thought to be responsible for spreading the signal to
other parts of the dendritic tree (Eilers et al., 1996).
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Figure 3: Calcium signaling in cerebellar Purkinje neurons
Adapted from Hartmann and Konnerth 2005,
Left: Schematic of the calcium response to AMPAR activation.
Right: Schematic of the calcium response to mGluR1 activation.

The second input, climbing fiber activation or “the complex spike”, on the other
hand, results in a widespread signal that originates in the proximal dendrites (where
climbing fibers synapse) and can be carried into the soma and the distal portions of the
dendritic tree (Eilers et al., 1996). Presynaptic release of glutamate initiates the complex
spike by activation of AMPARs and mGluR1s located on the postsynaptic PN plasma
membrane. This triggers fast, inactivating sodium currents which are responsible for the
initial fast components of the spike. Slow, non-inactivating sodium currents, P/Q-type
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currents, and T-type currents shape the slower complex spike components. Finally, K+
currents are mainly responsible for the repolarization of the complex spike, but have been
implicated in a number of other roles (Schmolesky et al., 2002). Approximately 50% of
the K+ current is the result of calcium-dependent potassium current activation
(Schmolesky et al., 2002), and it has recently been suggested that RyR-mediated calcium
stores might be a contributing source of calcium to these channels (Edgerton and
Reinhart, 2003; Gruol et al., 1996; Brorson et al., 1991). There is also evidence that
RyRs contribute to calcium signals evoked by both mGluR and AMPAR activation
(Gruol et al, 1996).
There are two major GABA-ergic inhibitory synapses on Purkinje neurons;
stellate cells, which synapse onto dendritic regions of the PNs and are located in the
molecular layer of the cerebellum, and basket cells, which synapse onto the soma and
proximal dendrite and are located in the molecular layer as well, but are closer to the
Purkinje cell layer than stellate cells (Schilling et al., 2008). Signals from these four
regulators of PNs are integrated and sent to the deep cerebellar nuclei where PN GABAergic axonal projections synapse.
Release of calcium from intracellular stores is immensely important for the
calcium dynamics of PNs.

The ER stores themselves form a continuous network

throughout PNs, and are present even within dendritic spines (Terasaki et al., 1994). The
IP3R is also expressed throughout the cell and into the spines, while the RyR1 is
expressed everywhere except the spines (Martone et al., 1993). Another indication of the
importance of calcium signaling within these cells is the great capability of these cells to
regulate free calcium. Calbindin D28K and parvalbumin, endogenous, cytosolic calcium
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buffering proteins, are very highly expressed in Purkinje neurons (Celio, 1990), and these
two proteins along with the contribution of immobile calcium buffering machinery
account for an enormously high calcium buffering capacity within Purkinje neurons
(Fiero et al., 1996). The calcium binding ratio of PNs is about an order of magnitude
higher than other neuronal cell types. Calcium signaling can also be important for
nuclear functions.

Calcium signals originating from depolarization of the plasma

membrane can reach the nucleus; RyRs amplify these somatic calcium signals and set the
gain of nuclear calcium signals (Gruol et al., 2010).
The RyR plays a diverse number of roles in different cells, but the specific
contribution of the RyR1 within PNs has yet to be elucidated. Since RyR2 and RyR3 are
much more prevalent in other neuronal cell types, this begs the question: why are RyR1s
expressed in PNs? Using the recently created mouse model of MH, Y522S-RyR1, we
hope to learn more about the function of this specific channel in the brain. This study
shows that the MH mutant form of RyR1 exhibits an enhanced leak through the RyR1 at
elevated temperatures, and a decreased threshold for activation by caffeine. RyR1Y522S/+
mutant mice are, therefore, a unique tool that can be used in future studies to examine the
functional effects of altered RyR1 activity on PN excitability and firing behavior.
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Chapter Two: Methods
Genotyping of Y522S-RyR1 mice
The protocol for genotyping of Y522S-RyR1 mice was modified from the
procedures described by Chelu et al., 2006. Genomic DNA was isolated from ear
punches using the Promega Wizard SV Genomic DNA Purification System (Promega
Corporation) and subjected to PCR with primers (Invitrogen). Amplified DNA was
cleaned using an E.Z.N.A Cycle Pure Kit (Omega bio-tek), and digested with Blp1.
Digested samples were run on a 1.5% agarose gel containing ethidium bromide (110 mV
for 30 minutes). Imaging of the gel was accomplished using a Bio-Rad chemi-doc
system.
Dissociation of cerebellar cells
Two to three week old wild-type and Y522S-RyR1 mice were cervically
dislocated, and cerebella were quickly dissected and submerged in ice-cold calcium and
magnesium free phosphate-buffered saline (CMF-PBS). Meninges were removed and
cerebella were transferred to a fresh culture dish containing a 0.1% papain solution and
minced. These dishes were then placed into a 37˚C incubator for 45 minutes, with
agitation every 10-15 minutes. After the incubation period, the cerebellar pieces were
rinsed twice with CMF-PBS and transferred to clinical centrifuge tubes containing 2 mL
of dissociation media. Cells were mechanically separated by trituration with three
increasingly small diameter fire-polished Pasteur pipettes. Cerebellar cell suspensions
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were then filtered through a 50 µm BD Falcon cell filter and collected. Cells were then
plated on poly-ethylene imine coated glass cover-slip culture dishes (density of 3x106
cells/mL), and incubated at 37˚C overnight.
Identification of dissociated Purkinje neurons
PNs were visually identified by their large soma and apical dendritic stump.
Visual identification of PNs was confirmed by immunocytochemistry (Fig 4). PNs are
the only cerebellar cell to express the calcium buffering protein calbindin D28K, and
antibodies to this PN specific protein can be utilized to determine cellular identity.
Cerebella were dissociated and plated on glass-insert cover-slip dishes as described
previously and fixed in 4% paraformaldehyde. These dishes were then rinsed repeatedly
over a thirty minute period with PBS. Non-specific binding was prevented by incubation
in a blocking solution (5% BSA/0.2% Triton X-100 in PBS). Following the blocking
step, dishes were incubated overnight at 4˚C with anti-calbindin D28K primary
antibodies (Millipore; 1:1000 in blocking solution, rabbit-α-mouse). Fluorescence from
conjugated secondary antibodies (Alexa-fluor 488; 1:1000 in blocking solution, goat-αrabbit) was detected with a Hamamatsu CCD camera and analyzed using Slidebook
software (Intelligent Imaging Innovations).
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Figure 4: Visual identification of dissociated Purkinje neurons
Cerebellar cells isolated from a 3 week old Y522S
Y522S-RyR1
RyR1 mouse and cultured for
18 hours. Standard
ndard immunochemical procedures were used to stain Purkinje cells
with a calbindin-D28K
D28K antibody. Scale bar = 20 µm.

Immunohistochemistry
Cerebella were fixed in 4% paraformaldehyde, paraffin
paraffin-embedded,
embedded, and sliced
sagittally (10 µm)
m) on a microtome. Non-specific binding was prevented by incubation in
a blocking solution (5%
5% BSA/0.2% Triton X
X-100 in PBS). Cerebellar slices were
incubated with anti-calbindin
calbindin D28K (Millipore; 1:1000 in blocking solution,
solution rabbit-αmouse), a well-established
established PN marker (Jande et al., 1981). Following conjugation with
secondary antibodies (Alexa
Alexa-fluor 488; 1:1000 in blocking solution, goat-α-rabbit),
goat
the
cerebellar slices were imaged on a confocal microscope using Olympus Fluo-view
Fluo
software.
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Calcium Imaging Experiments
Cerebellar Purkinje cells were dissociated and plated as previously described.
Twelve to twenty four hours after plating, neurons were loaded with the membranepermeable Ca2+ indicator dye, Fura-2 AM (5 µM; 30 minutes at RT). Cells were then
rinsed three times with rodent ringer’s solution (in mM: 145 NaCl, 5 KCl, 2 CaCl2, 1
MgCl2, 10 HEPES, 10 glucose, pH 7.4) and incubated at room temperature for at least
another 15 minutes to allow for de-esterification of the Fura-2 AM. Following this
incubation, dishes were imaged on an Olympus microscope with a Hamamatsu CCD
camera using Slidebook software (Intelligent Imaging Innovations). Changes of
intracellular calcium levels in Purkinje cell somata were measured with dual excitation
wavelength ratiometric imaging (340/380 nm excitation ratio) and expressed either as the
raw F340/380 ratio or the change in F340/380 ratio (∆Ratio= Rtest-Rbaseline). All measured
responses were below the saturation point of Fura-2. All recordings were made using a
40x dry objective and images were taken every second with a 100 millisecond exposure
to 340/380 excitation. Images were binned 4x4. For experiments using a 37˚C bath,
temperatures were controlled with an automatic temperature controller (Warner
Instrument Corporation). All solutions used in calcium imaging were prepared in regular
rodent ringer’s (RR) solution containing (in mM) 145 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10
HEPES, 10 glucose, pH 7.4. Nominally calcium-free RR solutions were prepared with
equimolar substitutions of MgCl2 for CaCl2 and the addition of 1 mM EGTA.
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Dose response to caffeine
Caffeine solutions were prepared in regular rodent ringer’s solution at
concentrations of (in mM) 1, 5, 10, 30, and 50, and applied to dissociated PNs that were
loaded with Fura-2 AM as previously described. Caffeine solutions were applied with a
fast multi-barrel perfusion system. PNs were either sequentially exposed to increasing
concentrations of caffeine or exposed to an individual application of one of the caffeine
concentrations. The duration of caffeine application was 60 seconds followed by at least
60 seconds of wash-out with regular rodent ringer’s solution.
Depolarization-induced calcium release
Dissociated PNs loaded with Fura-2 AM were depolarized by a 10 second puffapplication of a high K+ (80 mM) rodent ringer’s solution. PNs were depolarized at room
temperature and then again at 37˚C.
Store content and SOCE
Dissociated PNs were loaded with Fura-2 AM as described previously, but were
rinsed with nominally calcium-free rodent ringer’s solution prior to imaging. Baseline
F340/380 ratios were recorded for at least a minute prior to application of 1 µM
thapsigargin (in calcium-free RR). For store-operated calcium entry (SOCE), after the
F340/380 ratio had returned to baseline, a 2 mM calcium RR solution was applied for 90
seconds.
Statistical Analysis
All statistical analyses were performed using the unpaired Student’s t test, unless
otherwise stated. Area under the curve was determined by calculating ∆F340/380 ratios
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(∆Ratio = Rtest-Rbaseline) for every data point recorded and summing all appropriate values
for each trial. Full-duration at half maximal amplitude was determined by counting the
number of data points for a given trace that were larger than the half maximal response.
Since data were recorded once every second this value was reported in seconds. The
same analysis was performed for full-duration at one-tenth maximal amplitude, except
that the data points that were counted corresponded to values larger than one-tenth of the
maximal response.
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Chapter Three: Results
Cerebellar structure and Purkinje cell morphology is not grossly altered in Y522SRyR1/+ mice
The first aim of our study was to determine if the morphology of Purkinje neurons
was altered in Y522S-RyR1 mice compared to wild-type as a result of altered RyR1
channel function. We did not observe any gross morphological defects in Y522S-RyR1
PNs, as we expected (Fig 5). This is consistent with findings in skeletal muscle. There
are no major structural deficits in RYRY522S/+ myotubes, although this mutation is
associated with development of abnormal mitochondrial morphology in adult cells
(Durham et al., 2008).
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Figure 5: Morphology of RyR1-Y522S/+ Purkinje neurons
Confocal microscopy of cerebellar section stained with antibody to the ‘Purkinje
cell marker’ calbindin-D28K (blue staining is nuclear staining with DAPI).
Images are z-compressions of several confocal optical sections from a wild-type
(Wt) or Y522S-RyR1/+ (Hz) cerebellum. Scale bar = 50 µm (top) and = 30 µm
(bottom).

Decreased threshold for activation in RyR1-Y522S/+ channels
One of the hallmark traits of MH is that the RyR1 in skeletal muscle cells exhibits
an increased sensitivity to caffeine (Chelu et al., 2006), and, as mentioned previously, this
increased sensitivity can be used as a measure to diagnose MHS (Allen et al., 1998).
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Whether the RyR1Y522S/+ mutation exhibits similarly altered function within the central
nervous system has not, to our knowledge, been addressed.
In order to ascertain the functional effects of this mutation on channel activity
within PNs, we exposed dissociated cells to the RyR1 agonist caffeine and recorded the
size of the associated calcium transient as the change in F340/380 ratios from baseline.
Specifically, regular rodent ringer’s (RR) solutions containing increasing concentrations
of caffeine (in mM: 1, 5, 10 and 30) were sequentially perfused onto PNs from wild-type
and RyR1Y522S/+ mice for 60 seconds followed by a 60 second wash period with RR. To
ensure that sequential (seq) applications of caffeine were not depleting the ER store, we
also perfused cells with an individual (ind) 60 second application of only one of the
caffeine containing solutions (Fig 6). We compared the responses from both of these
experimental paradigms in RyR1Y522S/+ neurons and found no significant differences in
the size of the response (change in F340/380 ratio from baseline), or the sensitivity of the
channel to caffeine (EC-50) (Fig 6). Interestingly, while the size of the responses were
also unchanged between the ind and seq trials in wild-type neurons, the average EC-50 of
wild-type cells perfused with only an individual caffeine solution is less than in the
sequential trials (ind=12.8±5.8, seq=30.3±4.3). However, the EC-50 from either wildtype trial was larger than the EC-50 from the RyR1Y522S/+ trials (Fig 6). We decided to
pool the data from both the seq trial and the ind because the responses were not
significantly different in size and sequential applications did not appear to be depleting
the ER store of calcium.
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Figure 6: Individual versus sequential caffeine dose response
(A, B) Dissociated Purkinje neurons were perfused with a single concentration of
caffeine (ind) or with sequentially applied (seq) increasing concentrations of
caffeine (1, 5, 10, 30 mM) and the change in fluorescence was measured using the
ratiometric calcium indicator dye Fura-2 in wild-type (ind, n=25, 14, 17, 19; seq,
n=20) (A), and Y522S (ind, n=27, 16, 22, 34; seq, n=27) (B) neurons. (C) Curves
were fit to the data using the “Michaelis-Menton” function in Kaleidagraph. To
show the leftward shift in the Y522S trials more clearly, the data was normalized
to the response to 30 mM caffeine, which was set to 1. The responses to all other
concentrations of caffeine were expressed as a fraction of the maximal change in
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F340/380 ratio. The data from the ind and seq trials were pooled (pool) and
shown on this graph as well. (D) Summary graph showing the calculated EC-50
values ± parameter error generated by Kaleidagraph.

We compared the responses from wild-type and RyRY522S/+ neurons and although
the size of the calcium transient in response to each the four caffeine solutions is not
significantly different between RyR1Y522S/+ neurons and wild-type neurons, the dose that
invokes maximal release is reduced in RyR1Y522S/+ cells. The maximal response to
caffeine (30 mM) is not significantly larger than the response to 5 mM caffeine in
RyR1Y522S/+ neurons (ts=0.841, df=106, p>0.05), indicating that at 5 mM caffeine
RyR1Y522S/+ neurons are maximally activated. However, in wild-type cells, the response
to 5 mM caffeine is significantly lower than the response to 30 mM caffeine (ts=2.871,
df=51, p<.01), indicating that maximal activation of wild-type cells is not achieved until
the application of 30 mM caffeine. The fact that RyR1Y522s/+ neurons are maximally
activated by lower concentrations of caffeine supports the apparent leftward shift in EC50 (Wt=21.1±5.5, Y522S=3.8±1.7) exhibited by RyR1Y522S/+ cells (Fig 7).
Since sensitivity to activation is affected by temperature in RyR1Y522S/+ myotubes
(Durham et al., 2008), we also performed this experiment at more physiological
temperatures (37˚C). At this temperature, there were no significant differences between
wild-type and RyR1Y522S/+ neurons. The presence of any difference might have been
obscured by the leftward shift in the EC-50 of wild-type cells (Wt 25=21.1±5.5, Wt
37=3.1±1.9) as a result of the temperature increase. Furthermore, the EC-50 for both
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wild-type and Y522S cells at 37˚C (Wt=3.1±1.9, Y522S=2.1±1.3) both fell between the
two lowest concentrations of caffeine applied (1 mM and 5 mM) to the cells. Future
experiments need to be performed with lower concentrations of caffeine, to determine
whether there is a difference in activation at this temperature. Although the EC-50 at
37˚C is not significantly shifted, RyR1Y522S/+ PNs exhibited an increase in the amplitude
of their response to 1 mM caffeine (ts=1.939, df=54, p<.05) when compared to the
amplitude of the response in wild-type cells. These data do suggest, however, that at 25˚C
there is a decreased threshold for activation.
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Figure 7: Decreased threshold for activation in RyR1Y522S/+ channels
(A) Dissociated Purkinje neurons were perfused with increasing concentrations of
caffeine (1, 5, 10, and 30 mM) at 25 degrees Celsius and the change in
fluorescence was measured using the ratiometric calcium indic
indicator
ator dye Fura-2
Fura
(Wild-type,
type, n=24, 34
34, 37, 39; Y522S-RyR1, n= 27, 43, 49, 61). (B) Dissociated
Purkinje neurons were also perfused with increasing concentrations of caffeine (1,
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5, 10, and 30 mM) at 37 degrees Celsius. The response to 1 mM caffeine was
significantly larger in Y522S neurons (unpaired t test, ts=2.266, df=57, P<0.05).
(Wild-type, n=31; Y522S-RyR1, n=38) (C) Summary graph comparing the EC-50
of curves fit to the data in Kaleidagraph using the “Michaelis-Menton” function.
Data are reported as the EC-50 ± the parameter error generated by Kaleidagraph.
(D) Representative traces of the responses at both temperatures for both wild-type
and Y522S neurons. Axis labels indicate the change in F340/380 ratio (∆F) and
caffeine concentration ([Caff]). Data in (A) and (B) are presented as the mean ±
SEM.

Increased intracellular calcium concentration in RyR1-Y522S/+ Purkinje neurons
The RyR1Y522S/+ mutation causes a decrease in the threshold for activation of the
RyR1 in PNs (Fig 7), suggesting that basal RyR1 activity might also be increased. If the
calcium buffering, extrusion, and sequestration machinery of the cell is not able to
compensate for enhanced activity of the RyR channel, this could result in an increase in
basal cytoplasmic calcium concentrations. In order to investigate whether altered RyR1
activation affects cytoplasmic calcium concentrations in PNs, we measured baseline
F340/380 ratios in wild-type and RyR1Y522S/+ neurons. Baselines were recorded for 30
seconds at room temperature (25˚C) and more physiological temperatures (37˚C). There
were no significant differences in F340/380 ratios at room temperature, but at elevated
temperature, the RyR1Y522S/+ neurons exhibited increased intracellular calcium
concentrations (Fig 8). PNs, therefore, are either capable of compensating for a slight
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increase in basal RyR1 activity at lower temperatures or RyR1 activity itself is not
enhanced without the challenge of elevated temperature.

Figure 8: Increased intracellular calcium concentration in RyR-Y522S/+
Purkinje neurons
Baseline fluorescence ratios, measured using Fura-2-AM, were recorded at room
temperature and more physiological temperatures. There is a significant
difference in intracellular calcium levels between wild-type (n=19) and Y522SRyR1 (n=22) cells at 37°C (unpaired t test; ts=1.828, df=23, P<0.05). Data are
presented as the mean ± SEM.
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Intracellular calcium stores are unaffected by the RyR1-Y522S/+ mutation
The ER serves as a source of calcium for a number of different vital cellular
functions, and calcium release from the ER can be mediated by RyR calcium channels
(Simpson et al., 1995). Chronically hyperactive RyR1 channels could potentially deplete
the ER of calcium, and indirectly affect a diversity of cellular functions. Since
RyR1Y522S/+ PNs appear to exhibit a decreased threshold for activation and an increased
cytoplasmic calcium concentration at higher temperatures, there is a possibility that the
ER calcium store content could be affected by this mutation. To address this issue, we
took a two-fold approach. First, we examined whether maximal calcium release from
RyR1-mediated calcium stores was altered by the RyR1Y522S/+ mutation. Dissociated
wild-type and RyR1Y522S/+ PNs were perfused with a RR solution containing 30 mM
caffeine for 60 seconds, and F340/380 ratios were recorded at both 25˚C and 37˚C. The
amplitude of the response was measured as the change in F340/380 ratio from baseline,
and the amount of calcium released was indirectly measured as the area under the curve.
There were no significant differences between the responses of wild-type and RyR1Y522S/+
neurons at either temperature (Fig 9).
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Figure 9: ER calcium store content is unaffected by the RyR1Y522S/+ mutation
as assessed by maximal doses of caffeine
(A) Representative traces from wild-type (25, n=23; 37, n=31) and Y522S (25,
n=39; 37, n=38) Purkinje neurons that were loaded with Fura-2-AM and perfused
with maximally activating concentrations of caffeine (30 mM) for 60 seconds.
This experiment was performed at room temperature (25) and more physiological
temperatures (37). Bars indicate duration of caffeine application. (B) The change
in F340/380 ratio from baseline.

There was no significant difference in the

amplitude of the response in any condition (p>0.05). (C) Area under the curve of
the response. There were also no significant differences in the overall size of the
response (p>0.05). Data are presented as the mean ± SEM.

Our second approach involved blocking the sarcoplasmic/endoplasmic reticular
calcium ATPase (SERCA) pharmacologically with the SERCA inhibitor, thapsigargin.
SERCA acts as a calcium pump that sequesters calcium into the ER store. Without a
functioning SERCA, calcium content in the ER cannot be replenished. Therefore,
activity of the RyR1 and/or IP3R will eventually completely deplete the ER of calcium.
As mentioned previously, intracellular calcium originates from either influx across the
plasma membrane, or release from internal stores. To ensure that measured changes in
F340/380 ratios were a function of release from internal stores, we applied 1 µM
thapsigargin to dissociated PNs bathed in a nominally calcium-free extracellular solution.
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There were no significant differences in either the amplitude, duration at half maximal
activation, or the area under the curve of the response to thapsigargin at either 25˚C or
37˚C (Fig 10). Although none of the differences were significant, it does appear that a
trend toward larger store content in RyR1Y522S/+ neurons exists. This is surprising given
the apparent hyperactive nature of mutant RyR1, but might be a result of compensatory
mechanisms.
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Figure 10: Store content assessed by thapsigargin
Dissociated wild--type and Y522S Purkinje cellss bathed in a nominally calciumcalcium
free extracellular solution were perfused with 1 µM thapsigargin and the resulting
change in fluorescence was recorded at 25
25˚C (A) and 37˚C
˚C (B). (C) The
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∆F340/380 was not significantly different between Y522S (25, n=22; 37, n=12)
or wild-type (25, n=24; 37, n=12) cells at either temperature. (D) The area under
the curve was also not significantly different between Y522S-RyR1 and wild-type
cells. (E) The duration of the response at half maximal activation was also
unaffected. Data are presented as mean ± SEM.

Store-operated calcium entry - a compensatory mechanism?
The RyR1Y522S/+ mutation causes increased RyR1 activity, therefore might be
partially depleting ER calcium stores. However, we did not observe any significant
alterations in the calcium store content; measured by maximal RyR activation and
SERCA inhibition (Fig 9 and 10). One possibility could be activation of an ER calciumstore refilling mechanism and store-operated calcium entry (SOCE) might serve this role.
PNs express the principal proteins typically associated with SOCE, STIM 1 and Orai 1
(Klejman et al., 2009). Store depletion results in clustering of these two proteins at
discrete puncta on the ER and plasma membranes, respectively (Klejman et al., 2009).
The rearranged proteins trigger calcium influx that can replenish the stores. To determine
whether RyR1Y522S/+ neurons exhibited increased SOCE, we depleted the ER stores of
RyR1Y522S/+ and wild-type neurons with 1 µM thapsigargin in a nominally calcium-free
extracellular solution and measured the responses. After calcium release from the stores
had ceased, indicated by a return of F340/380 ratios to baseline, a 2 mM calcium solution
was perfused into the dish and the resultant calcium response was recorded as F340/380
ratios. In wild-type PNs we recorded SOCE in 17 out of the 27 cells tested at 25˚C, and 2
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out of the 12 cells tested at 37
37˚C. While, in RyR1Y522S/+ PNs we recorded SOCE in 21
out of the 28 cells tested at 25
25˚C, and 2 out of the 12 cells tested at 37˚C.
˚C. Further
analysis on the cells tested at 37
37˚C
˚C was not performed, since only 2 out of the 12 cells
responded for both wild-type
type and Y522S PNs. For tho
those tested at 25˚C,
˚C, however, we
calculated the amplitude of the response as the change in F340/380 ratio from baseline,
and the area under the curve to assess the overall size of the response
response. Neither the
amplitude nor the area of the SOCE response was sig
significantly
nificantly different between wildwild
type and Y522S neurons at either temperature (Fig 11).. Thus, it does not appear that
differences in SOCE explain the normal store content in neurons exhibiting increased
RyR activity.
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Figure 11: SOCE-a compensatory mechanism?
Purkinje cells loaded with Fura-2-AM were bathed in nominally calcium free
extracellular solution and perfused with 1 µM Thapsigargin (black bar). Once the
response F340/380 ratio had returned to baseline, the extracellular solution was
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changed to a 2 mM calcium solution for 90 seconds (blue bar). (A) Schematic
representation of the experimental paradigm. (B) Traces showing the change in
F340/380 ratio from baseline in response to extracellular calcium. At 25˚C, SOCE
occurred in 9 out of 24 wild-type and 11 out of 22 Y522S cells. At 37˚C, SOCE
occurred in only 2 out of the 12 cells tested for both wild-type and Y522S
Purkinje neurons. Neither the amplitude (C), nor the area under the curve (D)
were significantly different at 25˚C. Further analysis was not performed on the
cells tested at 37˚C because so few cells responded at this temperature. Data are
presented as the mean ± SEM.

Effects of altered RyR1 function on cellular function
The effects of the RyR1Y522S/+ mutation on RyR1 function in PNs contribute to an
apparent lower threshold for activation and, furthermore, increased basal RyR1 activity at
physiological temperatures. However, the implications of altered RyR1 function on more
global calcium dynamics and cellular function in PNs are not fully understood. Even
though PNs express the isoform of the RyR that is typically associated with mechanical
coupling, most evidence suggests that CICR is the main pathway for activation in these
cells. By depolarizing PNs with a high potassium solution, we triggered calcium influx
through voltage gated calcium channels. This calcium signal would then be amplified by
calcium-induced calcium release through the RyR1. We measured the global calcium
response to depolarization in Y522S and wild-type cells as a means to elucidate the
consequences of altered RyR1 function on global calcium dynamics within PNs.
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Specifically, F340/380 ratios were recorded at both 25˚C and 37˚C, and the amplitude of
the response was calculated using the change in F340/380 ratio from baseline. The
overall size of the response was calculated using the area under the curve. When the
F340/380 ratio had returned to a baseline, we stopped recording the response. In some
cells, this baseline either overshot or undershot the original baseline. The number of
wild-type and RyR1Y522S/+ cells exhibiting this behavior did not appear to be different
(Wt 25: 2/10, Y522S 25: 5/15, Wt 37: 3/10, Y522S 37: 5/15 cells).
Since the initial phase of the response is likely due to calcium influx, and calcium
release through the RyR1 primarily contributes in later phases of the response, we
measured the full duration of the curve at both one-half maximal values (FDHM) and
one-tenth maximal values (FDTM). The amplitude, area, and the durations of the
response were not significantly different between wild-type and Y522S neurons (Fig 12).
However, some interesting trends in the data exist. The amplitude of the response
indicates a trend toward larger initial responses in wild-type neurons than in RyR1Y522S/+
neurons, and this trend is reversed when comparing either the area under the curve or the
duration of the response.
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Figure 12: Effects of the Y522S mutation on calcium dynamics
An 80 mM K+ solution was puff applied for 10 seconds onto dissociated Purkinje
that were loaded with Fura-2-AM and the calcium response was recorded as the
change in F340/380 ratio from baseline. (A) Traces showing the calcium response
to depolarization in each condition. (B) Summary graph showing the ∆F340/380
ratio. There were no significant differences between groups at either temperature.
(C) Summary graph displaying the area under the curve that was calculated for
each condition. There were no group differences for this measure. (D, E) Graphs
displaying the duration of time the size of the response was above either half of
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maximal activation (FDHM) or one-tenth of maximal activation (FDTM). There
were no significant differences between Y522S-RyR1 (n=15) and wild-type
neurons (n=10) for any of the measures. Data are presented as the mean ± SEM.
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Chapter Four: Discussion
The function of the RyR1 in skeletal muscle has been well established; membrane
depolarization induces a conformational change in L-type voltage-gated calcium channels
that, by mechanical coupling, triggers release of Ca2+ through the RyR1 (Beam and
Horowicz, 2004). It is unclear if the RyR1, which is highly expressed in cerebellar
Purkinje neurons, is involved in a similar type of mechanical coupling or acts solely
through a Ca-induced Ca2+ release mechanism. Furthermore, the role of calcium released
through the RyR1 is not clearly defined. The “cardiac”- and “brain”-RyR isoforms
(RyR2 and RyR3) are more generally expressed throughout the cerebellum, while the
“skeletal”-isoform (RyR1) is limited in expression within the brain (Ledbetter et al.,
1994, Giannini et al., 1995). This begs the question: does RyR1 function differently in
Purkinje cells than RyR2 or RyR3 does in other neuronal cell types? There are currently
no commercially available isoform-specific pharmacologic agents directed against RyR1.
Thus, a mutant form of the RyR1 that alters channel function could potentially serve as a
unique tool to assess the individual contribution of this RyR isoform to PN function.
The RyR1Y522S/+ mutation has been shown to affect RyR1 channel activity in
skeletal muscle. Mutant channels are hypersensitive to activation by agonists (caffeine,
voltage, and temperature) and exhibit enhanced basal activity contributing to increased
intracellular calcium concentrations at higher temperatures (Chelu et al., 2006; Durham et
al., 2008). However, to our knowledge, no previous study has examined whether MH
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mutations exhibit similar phenotypes in non-muscle cell types. RyR1 expressed in a
neuronal environment might behave differently than RyR1 expressed in skeletal muscle,
and the etiology of an MH mutation might not be restricted to skeletal muscle cells. Our
results indicate that this mutant RyR1Y522S/+ in PNs, exhibits a decreased threshold for
activation by caffeine, and increased basal intracellular calcium concentrations at
physiological temperatures and therefore represents a valid tool to examine altered RyR1
function within PNs.
Calcium release from the ER can be induced by the RyR agonist caffeine, and an
increased sensitivity of RyR1Y522S/+ to this compound within skeletal muscle cells has
been well documented. We used caffeine to determine if the RyR1Y522S/+ mutation affects
the threshold for channel activation in PNs, and discovered that mutant channels exhibit a
decreased threshold for activation. However, at higher temperatures there were no
significant differences in the threshold for activation. To fully understand the
consequences of altered RyR1 activation as a result of the RyR1Y522S/+ mutation in PNs, it
is important to distinguish what is known about RyR1 in skeletal muscle from what we
know about RyR1 in PNs. The regulatory proteins that are associated with RyR1 in
skeletal muscle are not necessarily expressed in PNs. Although, at least some of the key
players expressed in skeletal muscle are present in PNs. RyR1 associates with
calsequestrin in skeletal muscle, and calsequestrin is expressed in PNs of the chicken
(Volpe et al., 1993), but it is unclear if calsequestrin has the same functional interactions
in PNs. In addition, it is currently unknown if RyR1 is arranged in PNs in orderly arrays
as it is in skeletal muscle. RyR1s, in skeletal muscle, that are not functionally coupled to
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neighboring channels do not maintain a stabilized closed state as well as RyR1s that are
coupled with their neighbors (Liang et al., 2009), so this could potentially account for
observed differences in channel function. Another important question is whether RyR1s
are activated by mechanical coupling or CICR in PNs. There is strong evidence that
RyRs in PNs are associated with CICR (Kano et al., 1995) and the presence of
mechanical coupling is unlikely as there is no calcium release when PNs are depolarized
in zero extracellular calcium solution (Eilers et al., 1996). Furthermore, P-type voltagegated calcium channels carry ~90% of the calcium current in response to depolarization
in PN and are likely the main contributors to activation of RyR1 (Mintz et al., 1992).
While in skeletal muscle, L-type voltage-gated calcium channels physically interact with
the channel and depolarization induces a conformational change in the DHPR that results
in activation (Tanabe, 1990). L-type voltage-gated calcium channels are also expressed
in PNs (Ahlijanian et al., 1990), but the function of these channels remains unclear, a
recent study suggests a larger role for L-type channels early in development (Gruol et al.,
2006).
Whether altered activation of the RyR1 due to the RyR1Y522S/+ mutation affects
PN morphology is an important question to address. MHS individuals may be suffering
from neurological symptoms that may be overlooked, since the characteristic skeletal
muscle defects are overshadowing. Thus, the effects of MH mutations on cerebellar
cellular organization and neuronal morphology need to be addressed as many processes
involved in development are regulated by calcium. Using confocal microscopy, we
determined that the RyR1Y522S/+ mutation does not appear to grossly alter PN morphology
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(Fig 4). Previous studies of the effects of the RyR1Y522S/+ mutation on skeletal muscle
cell morphology, revealed no major structural differences, but did find swollen and
abnormal mitochondria in adult mutant mice due to an enhanced basal leak of calcium
through the RyR1 (Durham et al. 2008).
Increased intracellular calcium levels can, over time, result in excessive
production of reactive nitrogen species (RNS) by nitric oxide synthases within the cell
(Durham et al., 2008). Lingering RNS can enhance S-nitrosylation of the RyR1 on cys
3635, which lies in the calmodulin binding domain (Sun et al., 2001). S-nitrosylation acts
to exacerbate calcium leak through the RyR1 through two main mechanisms. The first is
that S-nitrosylation increases the Kd of CaCaM for the RyR1 (the calcium-bound,
inhibitory form of calmodulin) which reduces calmodulin’s inhibitory actions on the
channel (Boschek et al., 2007). The second is that S-nitrosylation increases the Kd of
calstabin for the RyR1, which destabilizes the closed state of the channel resulting in an
enhanced leak (Bellinger et al., 2009). In the RyR1R615C/+ porcine model of MH, it has
been proposed that calstabin depletion interferes with the ability of RyR1 to interact with
neighboring channels, thus leading to both enhanced calcium release in response to
halothane, and a basal calcium leak through the RyR1 (Liang et al., 2009). Consistent
with the notion of an enhanced calcium leak, we observed larger Fura-2 fluorescence
ratios at 37˚C in RyR1Y522S/+ PNs than in wild-type PNs (Fig 8).
Even though RyR1Y522S/+ PNs exhibit a calcium leak, work in our lab has not
detected any changes in the amount of cellular and mitochondrial stress present in PNs.
The levels of lipid peroxidation in RyR1Y522S/+ cerebellar neurons, as measured by MDA
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equivalents, are not significantly different than the levels of lipid peroxidation in wildtype neurons (Santiago and Lorenzon, unpublished data). This suggests that the
phenotype of MH might be more severe in skeletal muscle cells, however whole
cerebellar lysates were used in these experiments, and since PNs only make up about
10% of the cerebellum, actual differences in cellular stress may have been masked by the
nature of the experiment. Future studies will be performed on Purkinje neuron enriched
preparations to further investigate this phenomenon.
Lipid peroxidation is a measure of stress directly resulting from action of reactive
oxygen species (ROS), but the negative effects of the RyR1Y522S/+ mutation within
skeletal muscle appears to be more directly related to the action of reactive nitrogen
species (RNS). In order to determine if the production of RNS is enhanced in Y522SRyR1 PNs in response to elevated levels of calcium, isolated PNs were loaded with DAFFM (a NO indicator dye) and exposed to high levels of glutamatergic stimulation. Even
though glutamate increased the intracellular concentration of calcium, preliminary
experiments demonstrated that the production of NO was not significantly increased in
either Y522S-RyR1 or wild-type neurons (Although there appeared to be a trend toward
an increase in NO production: Santiago and Lorenzon, unpublished).
Interestingly, it has been found that the RyR has essentially two separate release
pathways, one that is insensitive to inhibitory concentrations of ryanodine, and one that is
blocked by ryanodine (reviewed by Eltit et al., 2010). The ryanodine insensitive
conformation of the RyR1, thought to be the calcium “leak” pathway, is active at rest and
can be blocked by bastadin 5 (Eltit et al., 2010). This pathway is the main source for
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maintaining resting levels of intracellular calcium, contributing approximately 50% (Eltit
et al., 2010). It is unclear which of these two proposed pathways are responsible for the
MH phenotype, or whether both are involved. Since the ryanodine-insensitive pathway
seems to be mainly responsible for setting cytoplasmic calcium levels, it seems that the
presence of increased intracellular calcium concentrations in RyR1Y522S/+ neurons is
likely the result of the “leak” pathway. The classical form of calcium release, or the
ryanodine-sensitive pathway, might also be affected by the RyR1Y522S/+ mutation in PNs,
because caffeine activates the RyR by increasing A-site affinity to the endogenous ligand,
calcium (Meissner et al., 1997). Theoretically, increases in activity of either of these
pathways could result in increased calcium signaling, increased cytoplasmic calcium
levels and/or a depleted ER calcium store.
ER calcium store content does not appear to be significantly affected in PNs with
the RyR1Y522S/+ mutation. Even though RyR1Y522S/+ mutants exhibit hypersensitivity to
activation, the amount of calcium released in response to maximal activation, was not
different. Consistent with our results, RyR1Y522S/+ skeletal myotubes do not show
depletion of SR calcium stores (Chelu et al., 2006). Furthermore, the porcine model of
MH, RyR1R615C/+, exhibits a calcium leak and an increased sensitivity to activation, but
no depletion of calcium stores (Liang et al., 2009). Furthermore, assessment of the
content of the ER stores with the SERCA poison, thapsigargin, did not yield any
significant differences between wild-type and RyR1Y522S/+ neurons.
One possible mechanism that could contribute to refilling the stores and
compensation for excessive calcium leak is store-operated calcium entry (SOCE). SOCE
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is a pathway of calcium influx that is triggered by store depletion, and the calcium that
enters the cytoplasm can be sequestered into the ER by SERCA. STIM1, which resides
in the ER membrane, senses intra-luminal calcium levels and clusters to form discrete
puncta when calcium stores are depleted (Klejman et al., 2009). Orai1, a protein residing
in the plasma membrane, also forms clusters that create overlapping puncta with STIM1.
Following protein clustering, calcium flows inward through store-operated calcium
channels, the exact molecular make-up of these channels is still unclear, but it is thought
that Orai1 and possibly TRPC channels can form pores in the plasma membrane that
allows calcium flux into the cytosol (reviewed by Hewavitharana et al., 2007). SOCE
has not, to our knowledge, been directly measured in PNs, although STIM1 expression
has been demonstrated in these cells (Klejman et al., 2009). Thus, we investigated if
SOCE is present in PNs and if SOCE is altered in RyR1Y522S/+ PNs. PNs do express
SOCE, but the size of the response is unchanged by altered RyR1 activity in RyR1Y522S/+
cells. Furthermore, since SOCE is unchanged in RyR1Y522S/+ neurons, it is unlikely that
this phenomenon serves as a compensatory mechanism for an enhanced leak.
After characterizing how the RyR1Y522S/+ mutation affects channel function, we
hoped to investigate the affects of this mutation on cellular calcium signaling by
depolarizing RyR1Y522S/+ and wild-type PNs with a high potassium solution. While no
significant differences were found between F340/380 responses, there were some
interesting trends in the data. Wild-type responses appeared slightly larger in amplitude,
but when examining the duration of the response this trend reverses. Differences in
global calcium responses might be revealed using inhibitory concentrations of ryanodine
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during periods of depolarization; pharmacological subtraction of RyR-mediated calcium
release might reveal more subtle differences in calcium dynamics.
Although the functional consequences of the RyR1Y522S/+ mutation might differ
between cell types, the presence of an enhanced leak and an increased sensitivity to
caffeine in PNs suggests that perhaps the MH-phenotype is not constrained solely to
skeletal muscle. Furthermore, this mutation represents a valuable tool to further
investigate the role of RyR1 in PNs.
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Chapter Five: Summary
Our study represents the first examination of the consequences of an MH-inducing
mutation in a non-muscle environment. We have found that Y522S-RyR1 PNs exhibit an
enhanced basal leak at physiological temperatures, and an enhanced sensitivity to
agonists without affecting store content. In addition, SOCE does not appear to be a
compensatory mechanism for enhanced calcium leak through the RyR1, but further
investigation of this phenomenon is warranted. Now that we have determined that this
mouse model of MH is a valid tool to examine altered RyR1 function within PNs, we
hope to determine how this mutation affects the excitability and firing behavior of the
cell.
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